Anti-human immunodeficiency virus activity of polyhydroxy fullerenes in vitro

被引:0
|
作者
Schinazi, RF
Chiang, LY
Wilson, LJ
Cagle, DW
Hill, CL
机构
来源
PROCEEDINGS OF THE SYMPOSIUM ON RECENT ADVANCES IN THE CHEMISTRY AND PHYSICS OF FULLERENES AND RELATED MATERIALS, VOL 4 | 1997年 / 97卷 / 14期
关键词
D O I
暂无
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Polyhydroxy fullerenes (henceforth fullerenols) prepared by three different methods were evaluated for antiviral activity in cell culture. While all the fullerenols were active against HIV-1 in acutely infected primary human lymphocytes (EC50 values of 15-42 mu M in PBMC), none were active against chronically infected H9 cells. The cytotoxicity of the fullerenols ranged from low to very low in PBMC and Vero cells (IC50 greater than or equal to 68-100 mu M), but was more varied in CEM cells (IC50 = 3.4 to > 100 mu M). None of the compounds were as active in PBMC or H9 cells as those for the previously reported Wudl fulleroid and 3'-azido-3'-deoxythymidine (AZT). Two fullerenols had low but selective activity against herpes simplex virus type 1 in Vero cells.
引用
收藏
页码:357 / 360
页数:4
相关论文
共 50 条
  • [21] Anti-human immunodeficiency virus-type 1 activity of constituents fromJuglans mandshurica
    Byung Sun Min
    Hyeong Kyu Lee
    Sang Myung Lee
    Young Ho Kim
    Ki Hwan Bae
    Toru Otake
    Norio Nakamura
    Masao Hattori
    Archives of Pharmacal Research, 2002, 25 : 441 - 445
  • [22] AMINOSUGAR DERIVATIVES AS POTENTIAL ANTI-HUMAN IMMUNODEFICIENCY VIRUS AGENTS
    KARPAS, A
    FLEET, GWJ
    DWEK, RA
    PETURSSON, S
    NAMGOONG, SK
    RAMSDEN, NG
    JACOB, GS
    RADEMACHER, TW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) : 9229 - 9233
  • [23] ANTI-HUMAN IMMUNODEFICIENCY VIRUS (HIV) POSITIVE LABORATORY REAGENTS
    MURRAY, HGS
    CHAN, RCK
    TAM, JS
    SWAMINATHAN, R
    FRENCH, GL
    JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (07) : 813 - 813
  • [24] Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau
    Pontzer, CH
    Yamamoto, JK
    Bazer, FW
    Ott, TL
    Johnson, HM
    JOURNAL OF IMMUNOLOGY, 1997, 158 (09): : 4351 - 4357
  • [25] Polysulfated sialic acid derivatives as anti-human immunodeficiency virus
    Terada, M
    Fujita, S
    Suda, I
    Mastico, R
    BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 (08) : 423 - 429
  • [26] Rationale for the use of hydroxyurea as an anti-human immunodeficiency virus drug
    Lori, F
    Lisziewicz, J
    CLINICAL INFECTIOUS DISEASES, 2000, 30 : S193 - S197
  • [27] Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-τ in human macrophages
    Rogez-Kreuz, C
    Manéglier, B
    Martin, M
    Dereuddre-Bosquet, N
    Martal, J
    Dormont, D
    Clayette, P
    INTERNATIONAL IMMUNOLOGY, 2005, 17 (08) : 1047 - 1057
  • [28] POTENT INVITRO ANTI-HUMAN IMMUNODEFICIENCY VIRUS-1 ACTIVITY OF MODIFIED HUMAN SERUM ALBUMINS
    JANSEN, RW
    MOLEMA, G
    PAUWELS, R
    SCHOLS, D
    DECLERCQ, E
    MEIJER, DKF
    MOLECULAR PHARMACOLOGY, 1991, 39 (06) : 818 - 823
  • [29] Anti-human immunodeficiency virus activity of tau interferon in human macrophages:: Involvement of cellular factors and β-chemokines
    Rogez, C
    Martin, M
    Dereuddre-Bosquet, N
    Martal, J
    Dormont, D
    Clayette, P
    JOURNAL OF VIROLOGY, 2003, 77 (23) : 12914 - 12920
  • [30] Anti-human immunodeficiency virus-type 1 activity of constituents from Juglans mandshurica
    Min, BS
    Lee, HK
    Lee, SM
    Kim, YH
    Bae, KH
    Otake, T
    Nakamura, N
    Haftori, M
    ARCHIVES OF PHARMACAL RESEARCH, 2002, 25 (04) : 441 - 445